Evelo Biosciences - oral biologics producing systemic therapeutic results

Evelo Biosciences - oral biologics producing systemic therapeutic results

Products
Evelo Biosciences - oral biologics producing systemic therapeutic results
Evelo Biosciences - oral biologics producing systemic therapeutic results
Evelo Biosciences - oral biologics producing systemic therapeutic results
Evelo Biosciences - oral biologics producing systemic therapeutic results

Information

Evelo Biosciences is a clinical stage biotechnology company developing orally delivered product candidates that are designed to act on the small intestinal axis, with systemic therapeutic effects. This plays a central role in governing the immune, metabolic, and neurological systems. Evelo's therapies have the potential to improve the lives of people with inflammatory diseases, including COVID-19, and cancer. Evelo Biosciences and Abdul Latif Jameel Health announced a strategic collaboration in early 2021 to develop and commercialize novel therapy EDP1815 for inflammatory diseases and COVID-19, across select developing markets serving over 1.7 billion people. Contact us: info@aljhealth.com Learn more about our collaboration here: https://www.youtube.com/watch?v=_gLe9rSk0T0
Abdul Latif Jameel HealthS1.J10Abdul Latif Jameel Health - accelerating access, adding value.We are committed to adding real, tangible value, not only to all our business partner relationships but also to the communities in which we operate.As a solutions partner, we strongly believe in success through service – working together with stakeholders; taking a structured, systemic, focus to delivering on our promises.With this approach, we are accelerating access to modern medical care for more people in more places and for those that need it most.

Log in